These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Meredith TA; McCannel CA; Barr C; Doft BH; Peskin E; Maguire MG; Martin DF; Prenner JL; Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198 [TBL] [Abstract][Full Text] [Related]
45. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S Retina; 2008; 28(10):1395-9. PubMed ID: 18827737 [TBL] [Abstract][Full Text] [Related]
46. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400 [TBL] [Abstract][Full Text] [Related]
47. Incidence of acute endophthalmitis after office based intravitreal bevacizumab injection. Haider MA; Imtiaz U; Javed F; Haider Z J Pak Med Assoc; 2017 Dec; 67(12):1917-1919. PubMed ID: 29256542 [TBL] [Abstract][Full Text] [Related]
48. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China. Wang F; Yu S; Liu K; Chen FE; Song Z; Zhang X; Xu X; Sun X Ophthalmology; 2013 Feb; 120(2):355-61. PubMed ID: 23084126 [TBL] [Abstract][Full Text] [Related]
50. Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms. Sachdeva MM; Moshiri A; Leder HA; Scott AW J Ophthalmic Inflamm Infect; 2016 Dec; 6(1):2. PubMed ID: 26758203 [TBL] [Abstract][Full Text] [Related]
51. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics. Li AL; Wykoff CC; Wang R; Chen E; Benz MS; Fish RH; Wong TP; Major JC; Brown DM; Schefler AC; Kim RY; OʼMalley RE Retina; 2016 Jul; 36(7):1349-56. PubMed ID: 26655622 [TBL] [Abstract][Full Text] [Related]
53. Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center. Falavarjani KG; Modarres M; Hashemi M; Parvaresh MM; Naseripour M; Zare-Moghaddam A; Nekoozadeh S Retina; 2013 May; 33(5):971-4. PubMed ID: 23400076 [TBL] [Abstract][Full Text] [Related]
54. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. Jonas JB; Spandau UH; Rensch F; Von Baltz S; Schlichtenbrede F J Ocul Pharmacol Ther; 2007 Jun; 23(3):240-2. PubMed ID: 17593007 [TBL] [Abstract][Full Text] [Related]
55. [Vitreal surgery and etiological diagnosis of bacterial endophthalmitis]. Ye JJ; Guo LB; Wang SR; Wang WW; Min HY Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):995-1000. PubMed ID: 23302273 [TBL] [Abstract][Full Text] [Related]
56. Incidence of Endophthalmitis after Intravitreal Injections: Risk Factors, Microbiology Profile, and Clinical Outcomes. Mishra C; Lalitha P; Rameshkumar G; Agrawal R; Balne PK; Iswarya M; Kannan NB; Ramasamy K Ocul Immunol Inflamm; 2018; 26(4):559-568. PubMed ID: 29437495 [TBL] [Abstract][Full Text] [Related]
57. An outbreak of Ralstonia pickettii endophthalmitis following intravitreal methotrexate injection. Choudhury H; Jindal A; Pathengay A; Flynn HW Clin Ophthalmol; 2015; 9():1117-20. PubMed ID: 26150690 [TBL] [Abstract][Full Text] [Related]
58. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531 [TBL] [Abstract][Full Text] [Related]
59. Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients. Ng DS; Kwok AK; Chan CW; Li WW Hong Kong Med J; 2012 Dec; 18(6):488-95. PubMed ID: 23223649 [TBL] [Abstract][Full Text] [Related]
60. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Pilli S; Kotsolis A; Spaide RF; Slakter J; Freund KB; Sorenson J; Klancnik J; Cooney M Am J Ophthalmol; 2008 May; 145(5):879-82. PubMed ID: 18329624 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]